Blue Ribbon Study Panel On Biodefense Praises Passage Of Legislation Calling For Cross-Cutting Analysis On Federal Biodefense Spending

Homeland Preparedness News: Blue Ribbon Study Panel praises congressional action to unify biodefense budget
“Members of the Blue Ribbon Study Panel on Biodefense praised the passage of legislation that incorporates its recommendation to direct the Office of Management and Budget (OMB) to conduct a detailed analysis of the Trump administration’s budget for biodefense as part of the annual budget process. … Formed in 2014 to assess the state of U.S. biodefense efforts and to issue recommendations for improvement, the panel said in a written statement that such an analysis would help to determine capability and programmatic limitations in the nation’s biodefense strategy. … In September 2018, the White House released the National Biodefense Strategy, a top recommendation from the panel’s Blueprint for Biodefense, released in 2015…” (Rozens, 3/18).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.